Register
|
Login
The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
NEWS
CONFERENCES
VIDEOS
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Precision Medicine
PUBLICATIONS
Evolving Paradigms
Targeted Therapies in Oncology
The Journal of Targeted Therapies in Cancer
ONCAlert | Upfront Therapy for mRCC
Case Studies
Case Studies: Renal Cell Cancer
Expert physicians provide insight on managing oncology-based patient cases that highlight the use of novel agents in clinical practice.
SORT BY:
A-Z
Recent
VIEW AS:
Grid
List
TKI in Poor-Risk Advanced Renal Cell Carcinoma
Frontline TKI in Intermediate-Risk Renal Cell Carcinoma
Perspective on the Treatment of Advanced Renal Cell Cancer
Treatment of Refractory Metastatic Renal Cell Carcinoma
Therapeutic Approach for Metastatic Renal Cell Carcinoma
Intermediate-Risk Newly Diagnosed Metastatic Renal Cell Carcinoma
Metastatic RCC, Progressing on Multiple Therapies
Choosing Second-Line Therapy for Metastatic Kidney Cancer
JTT Articles
Participating Practices Commend CMS for OCM Changes
The Role of Liquid Biopsy in NSCLC Continues to Emerge
Rare Incidence of ICI-Related Hepatotoxicity Frequently Ends in Treatment Discontinuation
>> View Peer-Reviewed Articles
Most Popular
Enasidenib Granted FDA's Priority Review for IDH2-Mutant AML
CAR T Cells Push Forward in Solid Tumors Following Positive Results in Hematology
Chemo/SABR Combo May Allow Patients With Advanced Pancreatic Cancer to Undergo Surgery
FDA Approval Sought for Ide-cel in Relapsed/Refractory Multiple Myeloma
Publications
